GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanix Biotechnologies AG (FRA:ELN) » Definitions » 5-Year Yield-on-Cost %

Elanix Biotechnologies AG (FRA:ELN) 5-Year Yield-on-Cost % : 0.00 (As of May. 29, 2024)


View and export this data going back to . Start your Free Trial

What is Elanix Biotechnologies AG 5-Year Yield-on-Cost %?

Elanix Biotechnologies AG's yield on cost for the quarter that ended in Dec. 2018 was 0.00.


The historical rank and industry rank for Elanix Biotechnologies AG's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:ELN's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.13
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Elanix Biotechnologies AG's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Elanix Biotechnologies AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elanix Biotechnologies AG's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanix Biotechnologies AG's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Elanix Biotechnologies AG's 5-Year Yield-on-Cost % falls into.



Elanix Biotechnologies AG 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Elanix Biotechnologies AG is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Elanix Biotechnologies AG  (FRA:ELN) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Elanix Biotechnologies AG 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Elanix Biotechnologies AG's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Elanix Biotechnologies AG (FRA:ELN) Business Description

Traded in Other Exchanges
N/A
Address
Street-4, Georg-Glock, c/o HEUKING KÜHN LÜER WOJTEK, Dusseldorf, NW, DEU, 40474
Elanix Biotechnologies AG is a tissue regeneration company. It develops and commercializes products for acute wound care, dermatological and gynecological applications as well as providing cell technology services. The company's operating segment include Regenerative Medicine and Cosmetic ointments. It generates maximum revenue from the Cosmetic ointments segment. Geographically, it derives a majority of revenue from Switzerland and also has a presence in the EU, and Taiwan.

Elanix Biotechnologies AG (FRA:ELN) Headlines

No Headlines